Gladstone NOW: The Campaign Join Us on the Journey ✕
76 - 90 of 90 Results Clear All
Recent discoveries made at the Gladstone Institutes have provided new hope in the search for a cure for HIV/AIDS.
HIV/AIDS Greene Lab
Advances made in the fields of virology and immunology often spread from one disease to another.
Ott Lab Diabetes Hepatitis C HIV/AIDS
New generation of microbicides should contain compounds that break down amyloid fibrils in semen in order to increase drugs’ effectiveness.
HIV/AIDS Greene Lab
SAN FRANCISCO, CA—A team of scientists at the Gladstone Institutes has identified a new way to make latent HIV reveal itself, which could help overcome one of the biggest obstacles to finding a cure for HIV infection.
Weinberger Lab Infectious Disease HIV/AIDS
SAN FRANCISCO, CA—Research led by scientists at the Gladstone Institutes has identified the precise chain of molecular events in the human body that drives the death of most of the immune system’s CD4 T cells as an HIV infection leads to AIDS.
Greene Lab Infectious Disease HIV/AIDS
SAN FRANCISCO, CA—In 2012 the HIV antiretroviral drug Truvada became the first and only medication approved by the FDA for HIV prevention.
Grant Lab Infectious Disease HIV/AIDS
SAN FRANCISCO, CA—Perhaps the single greatest barrier to curbing the spread of HIV/AIDS is the dormant, or “latent,” reservoir of virus, which is out of reach of even the most potent medications.
Greene Lab Infectious Disease HIV/AIDS
SAN FRANCISCO, CA—Three Gladstone scientists have won research awards from divisions of the National Institutes of Health (NIH) equaling an approximate total of $12.5 million over five years for their groundbreaking research to overcome HIV/AIDS.
HIV/AIDS Infectious Disease Greene Lab Sanjabi Lab Weinberger Lab
SAN FRANCISCO, CA—New research from an international team of HIV/AIDS experts has reaffirmed the effectiveness of Truvada—the first and only medication approved by the FDA for HIV prevention.
Grant Lab HIV/AIDS
SAN FRANCISCO, CA—Scientists at the Gladstone Institutes have gotten us one step closer to understanding and overcoming one of the least-understood mechanisms of HIV infection—by devising a method to precisely track the life cycle of individual cells infected with HIV, the virus that causes AIDS.
HIV/AIDS Weinberger Lab
SAN FRANCISCO, CA—Gladstone Institutes scientist Nevan Krogan, PhD, today is announcing research that identifies how HIV—the virus that causes AIDS—hijacks the body's own defenses to promote infection. This discovery could one day help curb the spread of the HIV/AIDS pandemic.
HIV/AIDS Krogan Lab
San Francisco Business Times—Ten years ago, an international HIV study led by then Gladstone Investigator Robert Grant, MD, MPH, showed that the antiretroviral drug Truvada taken as a prophylactic could reduce the risk of infection by HIV, a study that was declared medical breakthrough of the year by Time magazine.
Gladstone Experts HIV/AIDS
SAN FRANCISCO, CA—Scientists at Gladstone Institute of Virology and Immunology have solved a long-standing mystery about HIV infection—namely how HIV promotes the death of CD4 T cells. It is the loss of this critical subset of immune cells that leads to the development of AIDS.
Greene Lab HIV/AIDS
San Francisco, CA—In a finding with the potential to fundamentally change strategies to slow the global HIV epidemic, a new study called iPrEx shows that individuals at high risk for HIV infection who took a single daily tablet containing two widely used HIV medications, emtricitabine and tenofov
Grant Lab HIV/AIDS
SAN FRANCISCO, CA—Scientists at the Gladstone Institute of Virology and Immunology (GIVI) have discovered a new agent that might inhibit the infectivity of HIV. The agent, surfen, impairs the action of a factor in semen that greatly enhances the viral infection.
Greene Lab HIV/AIDS
